Skip to content

Search Results

331 Results

Alternatives to managed care

Although knowledge is increasing regarding specific pathways and specific brain areas involved in mental disease states, at present the use of brain imaging to study psychiatric disorders is still considered a research tool. Continued study of child and adolescent psychiatric disorders using a variety of brain imaging methods, as well as refinements in imaging techniques, may result in evidence supporting the utility of these tools for clinical work in the future. Imaging research cannot yet be

Syringe Exchange Programs

According to the office of the United States Surgeon General, syringe exchange programs are an effective public health intervention strategy that reduces the transmission of HIV and hepatitis. Syringe exchange programs do not encourage the use of illegal drugs, but seek to prevent the harm caused by unsafe drug use.

The Interface of Religion, Spirituality, and Psychiatric Practice

Psychiatry has historically been known to have an adversarial relationship with religion. One example can be found in the writings of Sigmund Freud, who was dismissive of religion and viewed it as a form of mental illness. Freud drew parallels between the rituals of obsessional patients and those of very religious people and concluded that religion was a universal obsessional neurosis (Breakey 2001). However, there are also works throughout history demonstrating the harmonious relationship betwe

Neuroimaging

The application of neuroimaging technology in psychiatric research has revolutionized clinical neuroscience perspectives on the pathophysiology of the major psychiatric disorders. Research using a variety of types of neuroimaging techniques has shown that these conditions are associated with abnormalities of brain function, structure and receptor pharmacology. These data also corroborate the conclusions reached from genetic, endocrine, and clinical pharmacology research involving these disorders

Opposition to Cannabis as Medicine

The medical use of cannabis has received considerable attention as several states have voted to remove civil and criminal penalties for patients with qualifying conditions. Yet, on a national level, cannabis remains a schedule I substance under the Controlled Substances Act (CSA), the most restrictive schedule enforced by the Drug Enforcement Administration (DEA) (1). The Food and Drug Administration (FDA), responsible for approving treatments after appropriate and rigorous study, has not approv

Decisional Capacity Determinations in Consultation-Liaison Psychiatry: A Guide for the General Psychiatrist

Consultation-Liaison Psychiatrists are experienced in responding to requests from medical services for the determination of decisional capacity (DC). General psychiatrists are occasionally called upon to perform decisional capacity determinations, especially when functioning in a consultation-liaison role. Some may not have extensive prior or current experience in decisional capacity determinations. In recent years, there has been a significant amount of clinical research literature on DC, part

Consensus statement on "Managing the risks of repetitive transcranial stimulation"

In response to the changing managed care environment, the APA Committee on Managed Care established a subcommittee to document the changes in managed care and to begin the process of thinking about alternative healthcare financing systems. The Committee undertook writing a resource document for APA members to identify and describe the changes that are occurring in the healthcare sector and to prepare them for changes that may occur so that psychiatry can be proactive in meeting these challenges

Medical leadership for mind, brain and body.

Join Today